Concepedia

Lisa Licata

LL

Statistics

Publications

6

Citations

486

H-Index

6

Active since

1996

Affiliations

Johnson & Johnson (United States)(Current)

Lisa Licata is an author at Johnson & Johnson (United States) specializing in antimicrobial pharmacology, antibacterial pharmacology, and enzyme inhibition.

Publications per year

1996–2001

6

Publications

6

Multiple Mechanisms of Action for Inhibitors of Histidine Protein Kinases from Bacterial Two-Component Systems

Jamese J. Hilliard, Raúl Goldschmidt, Lisa Licata et al. · Antimicrobial Agents and Chemotherapy · 1999 · 166 citations · Full text

, , +15

Antibacterial agents that inhibit two-component signal transduction systems

John F. Barrett, Raúl Goldschmidt, Laura Lawrence et al. · Proceedings of the National Academy of Sciences · 1998 · 123 citations

, , +17

Identification and Characterization of New Inhibitors of the <i>Escherichia coli</i> MurA Enzyme

Ellen Z. Baum, Deborah A. Montenegro, Lisa Licata et al. · Antimicrobial Agents and Chemotherapy · 2001 · 105 citations · Full text

, , +14

Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae

Lisa Licata, C E Smith, Raúl Goldschmidt et al. · Antimicrobial Agents and Chemotherapy · 1997 · 51 citations · Full text

, , +9

Comparison of Efficacies of Oral Levofloxacin and Oral Ciprofloxacin in a Rabbit Model of a Staphylococcal Abscess

Jeffrey Fernandez, John F. Barrett, Lisa Licata et al. · Antimicrobial Agents and Chemotherapy · 1999 · 29 citations · Full text

, , +17

1–5 of 6